Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…
Invectys Inc. to participate in the 2022 JP Morgan Healthcare Meeting and Biotech Showcase, January 10-19, 2022 Houston, Texas, USA January 5th, 2022 (GLOBE…
Invectys Inc. is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers based in Houston, Texas, USA, with…
Invectys Inc. to participate in the 2021 Roth Virtual Healthcare Private Company Forum on June 28th, 2021 Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) –…
Invectys nominates Rosemary Williams, CPA, as Vice-President for Administration and Controller Houston, TX, USA, June 1st, 2021 (GLOBE NEWSWIRE) — Invectys…
ASCO Annual Meeting 2021 June 4th – 8th 2021 Invectys will be participating in the online 2021 ASCO Annual Meeting. Although online, this landmark event…
Invectys, Inc appoints Biopharma Veteran, Praveen Tyle, PhD as President & CEO Houston, TX, USA, May 4, 2021 (GLOBE NEWSWIRE) – Invectys, Inc., a clinical-stage…
AACR Annual Meeting 2021 April 10th – 15th 2021 Invectys was at the AACR’s Annual Meeting 2021. Although online, the AACR Annual Meeting still carried…
